Introduction
Premature ovarian failure (POF) is a hypergonadotropic ovarian deficiency with primary or secondary amenorrhoea affecting 1% of women before the age of 40 years (Coulam et al., 1986; Goswami and Conway, 2005; Fassnacht et al., 2006) . Between 4 and 31% of the patients with POF have a familial accumulation of the POF syndrome supporting a dominant genetic aetiology (Coulam et al., 1983; Vegetti et al., 1998; van Kasteren et al., 1999; Laml et al., 2002; Dixit et al., 2010) . Therefore, besides autoimmune diseases or infections, genetic factors are thought to be mainly responsible for POF development. With view to its original observation and description in 1942 (Albright et al., 1942) , POF is now also coined Primary Ovarian Insufficiency (POI) in order to remind the fact that 50% of the cases show a variable and unpredictable function of the ovarian reserve (Perlhoff and Schneeberg, 1957; Nelson et al., 1994; Welt, 2008) . Furthermore, 5-10% of women with POF conceive and deliver a child after they have received the diagnosis (Gleicher † These authors contributed equally to the results of this paper.
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For Permissions, please email: journals.permissions@oup.com Nelson, 2009; Cooper et al., 2010) . Therefore, it has been proposed that the POF/POI condition might only be the most severe form of a more common premature ovarian senescence (POS) syndrome found in about 10% of women in different populations .
Although human candidate genes of POF are localized on all chromosomes, they seem to be concentrated on the X chromosome (Krauss et al., 1987; Powell et al., 1994; Sala et al., 1997; Zinn et al., 1998; Marozzi et al., 2000; Prueitt et al., 2000; Schlessinger et al., 2002; Rao et al., 2005; Rizzolio et al., 2006 ; OMIM database ID #300510; #300511; #300604; #311360; www.ncbi.nlm.nih.gov/ omim). Three regions with clusters of POF candidate genes could be distinguished by investigating distinct X-autosomal chromosome translocations (Davison et al., 2000; Toniolo and Rizzolio, 2006) . Accordingly, these regions were designated as POF-1 (Xq26 -q28), POF-2 (Xq13 -q22) and POF-3 (Xp11.2-p22.1).
In POF-1, the Fragile X Mental Retardation 1 (FMR1) gene is the most prominent candidate gene. Dysfunction of FMR1 in men causes the Fragile X syndrome (FXS: OMIM database: ID #300624)-a severe neurological disorder. It is mainly caused by the amplification of an unstable CGG triplet in the 5 ′ untranslated region (UTR) of the gene's first exon beyond a number of 200, thereby repressing the gene's transcriptional and translational activity (Oostra and Willemsen, 2003) . Amplification of the CGG triplet number above the normal range (n ¼ 29 -30; Fu et al., 1991) towards the so-called premutation status (n ¼ 55-200) was found to be a high risk factor (1:20) for women to get POF syndrome (Conway et al., 1999; Sullivan et al., 2005; Allen et al., 2007; Wittenberger et al., 2007) . Accordingly, females from families with FXS diagnosed with a carrier status for the CGG premutation on one allele have a high risk (16 -26%) for getting POF (Allingham-Hawkins et al., 1999) . In contrast to this, the CGG premutation of the FMR1 gene was found only rarely (1:300) in the general female population (Cronister et al., 2005) . Men with a single FMR1 gene and a CGG permutation allele in exon 1 are suffering from a variable reduction of FMRP protein expression in their lymphocytes which causes moderate and variable cognitive deficit (Tassone et al., 2000a) . Later in life, this phenotype develops into one of the most common single-gene, late-onset neurodegenerative disorder, occurring in one of 3000 men and designated as Fragile X-associated tremor/ataxia syndrome (FXTAS: OMIM ID: #300623). However, CGG triplet numbers below the premutation status and above the normal value, the so-called intermediate stage (n ¼ 31 -54) , were also found to be associated with POI/POF (Bretherick et al., 2005; Streuli et al., 2009) . Some authors claim that this association is not general but probably dependent on the pattern of single nucleotide mutations (AGG) in the CGG repeat and on the X-chromosomal inactivation status (Tarleton et al., 2002; Bodega et al., 2006) . Indeed, in two POF-CGG association studies, it was reported that CGG repeat numbers between 31 and 54 could be found with similar frequencies as in POF patients also in the female controls (Chatterjee et al., 2009; Bennett et al., 2010) . However, in both studies, these female controls were not analysed for the putative occurrence of POS (primary ovarian senescence). Recently, it was found that also CGG numbers below n ¼ 26 are found predominantly only in POF patients. This suggests a general association of POF and POS with a functional drawback of the FMR1 gene encoded protein (FMRP) in human folliculogenesis. It is therefore believed that it probably controls quantitatively the woman's ovarian reserve (Gleicher et al., 2009 . If this holds true, the function of FMRP during human folliculogenesis should be considered genetically as a sensitive quantitative trait (Gilad et al., 2008) .
Indeed, FMRP is a functionally important RNA-binding protein located in the cellular RISC (RNA-Induced Silencing Complex) and controlling the level of translation of multiple transcripts (Schaeffer et al., 2003; Jin et al., 2004) . That means any relaxation of the gene's tight transcriptional and translational control mediated, e.g. by the CGG triplet numbers in exon 1 might then become a causative agent for POF or POS (see also .
In this study, we analysed comparatively the quantitative expression level of the FMR1 gene in the leukocyte RNA samples of patients with a clinically diagnosed idiopathic POF syndrome and of control samples, i.e. women with a normal menstrual history (called NMH group). In parallel, we analysed the number of CGG triplets on both FMR1 gene alleles of the same POF samples in order to reveal their putative influence on the variability of FMR1 expression. Moreover, we reveal the expression of FMRP (FMR1 encoded protein) in granulosa cells of different ovarian tissue sections.
Materials and Methods

Patient sampling
This study was approved by the local ethical committee of the University of Heidelberg. Accordingly, all blood samples were taken from the individuals of the POF and NMH group only after medical indication (POF group) and prior written informed consent. The same procedure was followed when receiving an aliquot of the ovarian biopsy of some women diagnosed by histology to have a normal folliculogenesis. Biopsies were performed because the women had a clinical diagnosis of follicular cyst formation.
A total of 120 patients enrolling consecutively in our endocrinological outpatient clinic were selected for the presence of 'idiopathic' POF syndrome with aid of an extensive clinical questionnaire according to Fassnacht et al. (2006) . All POF patients with either a putative history of autoimmune diseases or an iatrogenic background owing to earlier chemo-or radiation therapies were excluded. Also, patients with primary amenorrhoea and those with karyotype abnormalities causing Turner Syndrome (45,X0) were excluded. The remaining 'idiopathic' POF patient subgroup includes 74 individuals. With the same questionnaire, 42 healthy women being over the age of 40 years with still regular menstruation or a physiologically conditioned menopause were selected as our control group (NMH). NMH4 was chosen as a calibrator sample in all quantitative RT -PCR assays because her FMR1 expression was not only near the median value of the range of FMR1 expression values found in all control samples, but also because she had given birth to two children and was still undergoing regular menstruation cycles at the age of 50 years. For NMH4, we therefore can exclude not only POF/POI but also any other POS phenotype, as discussed by .
DNA/RNA isolation and quantitative RT-PCR analyses
DNA samples were prepared as described by Fassnacht et al. (2006) ′ located 1554 -1574 nts from ATG in FMR1 cDNA (Gene ID ENSG00000102081 extracted from: www.ensembl.org database). For expression analyses of the HPRT gene, we used the following primer pairs: h-HPRT-1-FP: 5 ′ -gac ctg ctg gat tac atc aaa gc-3 ′ located 229 -251 nts from ATG and h-HPRT-1-RP: 5 ′ -gga tta tac tgc ctg acc aag ga-3 ′ located 424 -446 from ATG in HPRT cDNA sequence (Ensembl Gene ID ENSG00000165704).
For analysis of the CGG repeat length in exon 1 of the FMR1 gene by PCR and subsequent analysis of this sequence region with the ALF express sequence automat (Pharmacia Biotech, Freiburg, Germany; Type Amersham 1050), we performed all PCR assays in a volume of 10 ml. The PCR mixture contained: 2.5 pM of each primer: (forward 0-1147 and reverse primer 0-1148; for primer sequences, see Baechner et al., 1993) , 200 ml of each dNTP, 0.4 U Taq polymerase; 1× PCR buffer (all from: Qiagen GmbH, Hilden Germany) and 40 ng of genomic DNA. Conditions for PCR were as follows: 5 min at 948C for the first denaturation step; 35 cycles of amplification with a time -temperature profile of 15 s. at 948C, 2.5 min at 688C, 3 min + 4 s/cycle at 688C, 3 min at 688C; with additional 4 min at 688C in the last cycle. Both primers were labelled with the fluorescent Cy5 dye (from TIB MOLBIOL Syntheselabor GmbH, Berlin, Germany; cat. no. Alexa 488). A 1.5-ml aliquot of PCR mix was resuspended in 7 ml of loading solution (Formamide, bromophenol blue) containing 100 and 300 bp internal markers. All samples, after denaturation at 958C for 5 min, were analysed on 6% denaturing polyacrylamide gel with 7 M urea. A 50 -500 size marker labelled with Cy5 dye was used for calculation of CGG triplet numbers. Electrophoresis was carried out in 0.6× Tris-borate-EDTA (TBE) Buffer at 1500 V/min. The helium-neon laser operated at a wavelength of 700 nm and a power value of 2.5 mW. Allele sizes and peak areas of fluorescent products were analysed with aid of the Fragment Manager software (Pharmacia GmbH).
In order to exclude the presence of large CGG triplet numbers not resolvable by the ALF sequence automat but only by Southern blot analyses (Southern, 1975) , we also performed blot hybridization experiments of all POF DNA samples with the a-32 P-dCTP radioactively labelled p2
probe containing FMR1 exon 1 with the CGG repeat as described by Stoyanova and Oostra (2004) . After EcoRI and EagI genomic DNA restriction the methylated and unmethylated FMR1 exon 1 allele located on the inactive and active X chromosome, respectively, can be distinguished by two different fragment lengths (2.5 and 5.2 kb). An increase of the CGG triplet number towards the premutation range (n ¼ 55 -200) and longer (n , 200) become then visible by an increase of one or both EcoRI -EagI fragments after autoradiography. Reaction conditions: 3 -5 U of restriction enzyme (EcoRI from, Thermo Fisher Scientific, Ulm, Germany; EagI from New England Biolabs GmbH, Frankfurt, Germany) were incubated with the DNA samples at 378C overnight and then loaded onto 1% 1× TBE gel. Electrophoresis was carried out at 100 V in the first hour, then at the 60 V overnight. After depurination in 0.25 M HCl, denaturation with 1.5 M NaCl + 0.5 M NaOH and neutralization in 1 M Tris Cl + 2 M NaCl, the gels were blotted on nylon membranes soaked in 20×SSC (3 M NaCl, 0.3 M sodium citrate) overnight. Before hybridization with Church buffer (0.5 M Na phosphate pH 7.0 + 7% SDS + 5 mM EDTA), salmon sperm DNA (Roche; cat. no. 1022364001) was added to the hybridization cocktail and the membrane incubated overnight with the 32 P labelled probe pP2.
Statistics
To calculate the asymptotic significance of the gene expression values in the two analysed groups, we used the Mann-Whitney U-test. A P-value of ,0.05 was considered to indicate a statistically significant difference (Wilcoxon, 1945) .
Immunohistochemical experiments
For immunohistochemical experiments with a monoclonal FMRP antiserum (MAB1C3: clone 1C3-1a; 1:200 v/v; Euromedex, Souffelweyersheim, France), we collected ovarian tissue samples from females who were diagnosed first clinically with follicular cyst development. After laparoscopy, however, only normal follicles in their gonads were identified by detailed histological inspection of their ovarian tissue sections. Aliquots of ovarian tissue biopsies were fixed in buffered formaldehyde and embedded in paraffin blocks. For immunohistochemical experiments, 4 mm tissue sections were prepared and mounted on SuperFrost Plus glass slides (Neolab, Heidelberg, Germany). After overnight storage at 378C, sections were de-paraffinized with xylene (3 × 10 min) and re-hydrated with an ethanol -water series. After washing for 3 min in permeabilization buffer (0.1 M Tris, 0.1 M NaCl, 0.1% Triton X-100; pH 7.4), the slides were incubated with 0.2 M boric acid, pH 7, at 608C overnight. Nonspecific cross-reactions were blocked with 20% acetic acid at 48C for 15 s. After pre-incubation of all slides in 3% goat serum (60 min at room temperature), incubation with the mouse monoclonal FMRP antiserum was performed overnight at 48C in 1% goat serum. For staining the slides after the antiserum reaction, we used the standard APAAP protocol (Dako Cytomation, Glostrup, Denmark). Subsequently, slides (APAAP treated) were stained with HistoMark red (Dunn KPL.; Gaithersburg, Maryland, USA) and counterstained with Gill's hematoxylin II (VWR International, Bruchsal, Germany) before mounting in Immu-Mount (Shandon, Pittsburgh, PA, USA).
Results
Comparative quantitative analyses of FMR1 gene expression in leukocytes
In our FMR1 expression study, we explored the gene transcript level in the leukocyte RNA samples of 74 POF patients with an 'idiopathic' history and compared it with that of 42 control samples (NMH samples). Four of them (POF5; POF6, POF10; POF11) had a family history of POF. FMR1 mRNA levels estimated in the leukocytes of our 74 POF patients displayed a surprisingly large variability ranging between 54 and 754% with regard to the control NMH4 as internal calibrator, i.e. setting its FMR1 expression value to '100%' (Table I ). In the 42 RNA samples of the NMH control group, FMR1 transcript levels also displayed some variance (Table I) although within a significantly lower range with an arithmetic mean value of 112% and a median of 95%.
This could be best demonstrated by comparative Box and Whisker plots (Fig. 1) . However, the obvious trend towards remarkable high arithmetic mean and median values (Fig. 1) , as well as a SD twice as much as in the control group was too large to reach statistical significance (Mann -Whitney U-test: P ¼ 0.091).
Variable FMR1 expression in POF patients is not associated with CGG triplet numbers in FMR1 exon 1
It has been reported that increased FMR1 expression levels in POF patients correlate with the number of CGG triplets in the gene 5 ′ UTR. We, therefore, estimated in the genomic DNA samples of the same 74 POF patients the number of CGG triplets in FMR1 exon 1 on both gene alleles. More than half of them (45 samples) displayed a number of CGG triplets in the normal range on both alleles (Table II) . However, despite this their level of FMR1 expression ranged from 0.54x (i.e. 54%; POF43) to 7.54x (754%; POF54) when compared with the expression of the NMH4 calibrator sample (¼100%) as described above. This was more variable than found for the two POF samples, POF99 and POF101, with one allele being in the so-called premutation range (n ¼ 80-90), the second allele being below the normal value (n ¼ 20). Since FMR1 expression in POF patients with CGG values below or above the normal range (26 , n . 34) might also depend on age and on the distinct allelic heterozygous or homozygous CGG number combination, i.e. whether one or both alleles are above or below the normal range , we divide our FMR1 expression data of our POF patients in subgroups. The main group consists of samples with 'normal (n)' CGG numbers on both gene alleles ('n/n'; 45 samples). Additionally, we distinguished subgroups with heterozygous (het) allelic constitutions, i.e. one 'n(ormal)' allele together with one 'l(ow)' or 'h(igh)' allele ('het n/l' and 'het n/h') and subgroups with homozygous (hom) alleles outside the normal range, i.e. 'l/l' 'l/h' and 'h/h' (Table II) . We subdivided these CGG genotype subgroups in the table according to their level of FMR1 expression and into two age groups to reveal some possible age dependency. For this we chose an arbitrary borderline of 33 years. FMR1 expression level was called 'normal' when it was still in a range of 20% above or below the transcript level of NMH4 our calibrator control; 'low' and 'high' when it was below and above this range, respectively (Table III) . Although we found a strong imbalance in patient numbers with regard to age, with 17 below and 57 above 33 years, we noticed more patients in the 'high' FMR1 expression subgroup in the older females. With respect to the total number of patients, this was not found in the 'normal' and 'low' FMR1 expression groups. If this outcome should reflect the well-known tendency towards a reduction in ovarian reserve with age, it would suggest that higher expression of FMR1 transcripts in leukocytes can indeed be diagnostic for this, as first suggested by . We also observed a slight tendency of reduced FMR1 expression levels in the group of patients with 'hom l/n' and 'hom l/l' CGG genotypes when compared with those with n/n CGG genotype. There were no 'hom h/h' CGG alleles in our POF patient collection (Table III) . The number of patients in the hom l/n or hom l/I group is however too low to draw some conclusions from this observation.
We then selected 15 POF patients, some of which had a high (.1.3; POF6; POF8; POF14; POF33; POF42; POF46; POF71), a low (,0.8; POF13) or normal range of FMR1 mRNA level (POF4; POF5; POF7; POF11; POF31; POF40; POF57) for identification of a putative mosaic status of the active CGG triplet allele. Such variability only becomes visible by appropriate Southern blots as described in the Material and Methods section. We could not identify an extraordinary CpG methylation status within the FMR1 CpG island (Fig. 2) . Moreover, we also could not identify any mosaic status of the CGG triplet number on the active X chromosome as shown in Fig. 2 for the genomic DNA sample with a known CGG premutation allele ('pre-mut'); nor did we reveal any long CGG repeat blocks, which cannot be resolved by the ALF sequence automat but only by Southern blots.
We therefore conclude that the observed variability of FMR1 expression is not caused by some individual gross variation of the CpG methylation status in the gene promoter CpG island domain.
FMRP is expressed after birth in female germline predominantly in granulosa cells
A general involvement of FMR1 expression in controlling ovarian ageing would suggest that the encoded protein (FMRP) is expressed in granulosa cells controlling ovarian maturation after birth (Binelli and Murphy, 2009; Gougeon, 2010) . We therefore analysed the expression of FMRP in normal human ovarian tissue sections from three girls, aged 5 months, 10 years and 19 years, by immunohistochemistry. We found no FMRP expression in the oocytes in these ovarian tissue sections, but a predominant expression of FMRP in the granulosa cells surrounding each oocyte (Fig. 3) . The observed decrease in the number of follicles between the samples was in normal range of the gradient of apoptotic follicle degeneration with age (Krysko et al., 2008; Ozgur and Oktay, 2008) .
Discussion
Variability of FMR1 expression in POF patients is independent of CGG triplet numbers
The FMR1 gene is transcribed and translated in many tissues, including leukocytes. FMR1 was therefore a suitable candidate gene to develop a reliable diagnostic expression assay using leukocyte RNA samples, possibly helping to identify any dysfunction of this prominent POF candidate gene during ovarian maturation in POF patients. We thereby rationalized that any visible variation in the FMR1 expression profile found in the leukocytes of patients with POF syndrome but not in the leukocytes of women with a normal menstruation history (NMH group) would point to the presence of some genomic FMR1 sequence mutations causing this visible change of the FMR1 expression profile.
One class of such genomic FMR1 mutations associated with POF has already been identified, namely the number of CGG triplets in FMR1 exon 1 beyond or below the normal range (26 , n . 34; Gleicher et al., 2009 . Indeed, the most frequent genetic cause of POF is an increase in the number of CGG triplet towards the so-called premutation range (n ¼ 55-200; Kenneson et al., 1997; AllinghamHawkins et al., 1999; Sherman, 2000; Allen et al., 2004; Tassone et al., 2007; Wittenberger et al., 2007; . However, also CGG triplet numbers below the pre-mutation range and outside the normal range are probably associated with distinct Fragile X gene expression and premature ovarian failure impairments of normal folliculogenesis. These were recently summarized under the term 'POI' (Gleicher et al., 2009 Nelson, 2009) .
In this paper, we now present strong experimental evidence that not only CGG triplet amplification might cause a change of the cellular FMR1 expression level and therefore POF, but also other genomic alterations are obviously regulating the FMR1 transcript level. We found a high FMR1 expression variance in leukocytes when the number of both CGG alleles was in the normal range, but only in the leukocytes of POF patients (Tables I and II) . Interestingly, above the age of 33 years, the number of women with a high FMR1 expression level seems to be increased (Table III) .
A non-linear relationship between the number of CGG triplets and the associated FMR1 transcript levels was found previously in patients with POF although only for a small sample size (Garcia-Alegría et al., These were subdivided into the group with a homozygous 'n(ormal/n(ormal)' CGG genotype (45 samples), a group with heterozygous (het) allelic constitutions, i.e. one 'n(ormal)' allele together with one 'l(ow)' or 'h(igh)' allele ('het n/l' and 'het n/h'), and in a group with homozygous (hom) alleles outside of the normal range, i.e. 'l/l' 'l/h' and 'h/h' (grey-toned differentially), according to 2007; Tejada et al., 2008) . We could confirm this non-linear relationship within our study population of 74 POF patients.
Putative agents causing FMR1 transcript variation other than CGG triplet numbers
In the literature, three further putative agents causing a variable FMR1 expression are discussed: (i) choice of the transcriptional start site (coined 'TSS') for FMR1, (ii) DNA methylation level in the CGG triplet block or its adjacent upstream CpG island because being part of the FMR1 promoter, (iii) compaction of the chromatin around the different FMR1 gene alleles controlled by specific post-translational histone modifications called 'chromatin histone code'.
(i) Expansion of the number of CGG triplets beyond normal range creates more than one TSS within a 50 nucleotide (nt) Figure 2 Southern blot hybridization of the two FMR1 gene alleles in a number of patients with POF, using the P 32 labelled p2 probe of the FMR1 gene. The female patients always contain two X chromosomes. One gene copy is usually completely methylated in the CpG island region of exon 1 according to its location on the inactive X chromosome. It is marked by a p2 hybridization signal to a FMR1 genomic fragment of 5.2 kb (marked on the left). The p2 hybridization signal marking the FMR1 genomic fragment of 2.8 kb (marked on the left) represents the FMR1 allele with an unmethylated CpG island region thus located on the active X chromosome: its fragment length confirms the presence of CGG repeat lengths in the normal range, as listed in Table II for these patient samples. No further genomic fragments could be identified in this Southern blot, indicating the additional presence of long CGG repeat tracts that could not be visualized by the sequence analyser. Moreover, no mosaic status of the CpG methylation pattern was found in the genomic DNA samples of these patients with POF as shown, compared with the control sample of a man with a known CGG premutation allele (see pre-mut at the left). Neither did we find complete CpG methylation of the second FMR1 allele, as shown by the absence of the 2.8-kb hybridization fragment in the control sample of a man with a CGG full mutation allele (see full-mut at the left). 13; 36; 43;102; 113 5; 7; 24; 31; 37; 40; 65; 83; 87; 94; 103; 107; 109; 114; 116; 120 6; 11; 33; 42; 46; 69; 71; 93; 97; 100; 111; 115 67; 84 28; 60; 70; 74; 85 10; 14; 34; 45; 56; 59; 63; 86 18 76; 77; 117; 118 82; 88; 90;101 Total number of patients in each group 5 1 6 1 3 2 5 8 1 4 4
They were called 'normal' when they were in a range of 20% above or below the transcript level of NMH4 our calibrator control; 'low' and 'high' when it was below and above this range, respectively. Additionally the different FMR1 expression groups were divided into two age groups choosing an arbitrary borderline of 33 years.
region located 130 nt upstream of the CGG repeats (Beilina et al., 2004) . The authors therefore speculated that increased FMR1 transcript levels are caused by the use of multiple TSSs. (ii) The degree of CpG methylation in the CGG triplet blocks upstream of one or both FMR1 gene alleles also influences the gene transcription rate (Pietrobono et al., 2002) . In males where a variable CpG methylation level in the CGG triplet block and the adjacent CpG island of the FMR1 functional promoter domain this was found to be associated with variable neurological deficiencies (FXTAS; Tassone et al., 1999; 2000a Garcia-Arocena and Hagerman, 2010) . It means that these males with a single FMR1 gene sometimes (but not always suffer) from the associated significant reduction of FMRP protein expressed in their lymphocytes (Tassone et al., 2000b) . Thus as in females, the FMR1 CGG premutation does not always cause a clinical phenotype (Allingham-Hawkins et al., 1999; Tassone et al., 2000a,b,c) . Besides CpG methylation patterns, methylation of two epigenetically controlled genomic sequence domains (FREE1 and FREE2) located upstream of the FMR1 promoter might be an additional or alternative transcriptional control agent. Both genomic DNA regions control the methylation level of the adjacent FMR1 promoter and therefore the FMR1 transcription rate as well (Godler et al., 2010) . (iii) Local changes in or around the chromatin domain of the FMR1 gene, or some variabilities of the general inactivation mechanism of the second X chromosome in adult females, might also control the transcription rate in this genomic region (Coffee et al., 2002; Gheldof et al., 2006) . However, local chromatin studies with FMR1 gene alleles containing different numbers of CGG alleles
were not yet reported and studying a putative correlation between the level of mRNA expression and X-inactivation in blood cells failed to display any significant correlations (Sang et al., 2008; Tejada et al., 2008) .
In this context it is worthwhile to recall that in 50% of cases the POF condition was found to be reversible, and that 5-10% of POF women can conceive and deliver a child after they have received their diagnosis of idiopathic impairment of their ovarian reserve . One explanation for these reversing phenotypes might be the involvement of epigenetic signals, such as DNA methylation and histone modification, controlling the transcriptional efficiency of the FMR1 gene as discussed earlier. However, we have to acknowledge that some of these signals might differ in leukocytes and granulosa cells depending on cell-specific transfactors. Moreover, a number of genes and signal pathways are known to be quantitatively involved in the rate of follicle loss. Thus, the large genetic heterogeneity with variable expressivities of distinct mutations in other functional folliculogenesis genes might cause a variable POF phenotype as well because of the individual genetic background.
FMRP expression in granulosa cells is a quantitative trait
Before birth, FMRP expression was found only in the oocyte in human fetal ovaries (Rife et al., 2004) . We therefore revealed in our own experiments a cellular shift of FMRP expression to granulosa cells when human follicles further mature after birth (Fig. 3) . It is well known that the cellular transcript level of the FMR1 gene directly controls the amount of FMRP in each cell by a negative feed back loop (Kenneson et al., 2001; Primerano et al., 2002) . This is probably managed by a binding capacity of FMRP specific to its own transcript via some purine-quartet motifs (Schaeffer et al., 2001) . It suggests that the cellular FMRP quantity located in the RISC (Jin et al., 2004 ) must be tightly controlled. Indeed, this protein is a major cellular translational repressor protein, binding to multiple transcripts and controlling the level of their translation (Laggerbauer et al., 2001; Schaeffer et al., 2003; Till, 2010 ). Any change in the level of the cellular FMR1 transcript and subsequently protein expression will therefore influence immediately the quantitative cellular level of proteins encoded by FMRP-interacting transcripts required in the same target tissue Gilad et al., 2008) . For the female germline, we therefore assume that expression of FMRP in granulosa cells, as first described in this paper (Fig. 3) , is probably a sensitive quantitative trait controlling the ovarian reserve, as was recently first suggested by Gleicher et al. (2009 .
During follicular maturation, the granulosa cells express multiple endocrine signals and functionally important genetically controlled signal pathways for proper maturation of the ooocyte. Among them are the gonadotrophins, FSH and LH, and proteins such as BMP15, inhibin and activin expressed along the transforming growth factor b signal pathway. If these products are quantitatively reduced or absent, they also will cause POS (McNatty et al., 2005; Miyoshi et al., 2006; Fassnacht et al., 2006; Binelli and Murphy, 2009; Gougeon, 2010) .
Quantitative trait loci influencing variation of menopausal age were recently also found for the genes of the POF3 region of the short arm of the X chromosome and expressed in the ovary (Van Asselt et al., 2004) . If this holds true also for the FMR1 gene in the POF1 region, as suggested by the data of this paper, any slight variation of FMRP expression in the granulosa cells of maturating follicles below or above the optimal level (Chen et al., 2003) might then immediately interfere with the process of folliculogenesis.
